✦ LIBER ✦

The susceptibility of human pulmonary adenocarcinoma cell treated with chemotherapeutic drugs to LAK cells

Book ID: 123238970
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 143 KB
Volume: 16
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(97)89548-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Empirical study on chemotherapeutic susc

Empirical study on chemotherapeutic susceptibility of SP cells in human pulmonary adenocarcinoma cell line A549in Vitro

✍ Tong Xie; Li Li; De-seng Liu; Nai-quan Mao; Dan-rong Li; Chuan-tian Zuo; Ding-mi 📂 Article 📅 2010 🏛 Springer-Verlag ⚖ 530 KB

Drug-mediated increase of susceptibility

Drug-mediated increase of susceptibility of human lung cancer to NK or LAK effector cells

✍ Stefania D'Atri; Stefano Marini; Lucio Tentori; Maria Tricarico; Maria Pia Fugge 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 955 KB

Drug-mediated increase of susceptibility

Drug-mediated increase of susceptibility of human lung cancer to NK or LAK effector cells

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Changes of surface antigens in drug-resi

Changes of surface antigens in drug-resistant human lung cancer cell lines and their susceptibility to LAK cells

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Study of the susceptibility of anti-tumo

Study of the susceptibility of anti-tumor drug resistant cells to IL-1 induced LAK cells

✍ K. Hirata; U. Lee; Y. Sakurai; Y. Sasakura; J. Sindo 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 216 KB

In vitro response of human small-cell lu

In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical data

✍ E. F. Smit; E. G. E. de Vries; H. Timmer-Bosscha; L. F. H. M. de Leij; J. W. Oos 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 844 KB

Three cell lines derived from small-cell lung carcinoma (SCLC) tumors of patients who had no clinical response after treatment with a multi-drug regimen were compared to 3 cell lines derived from tumors of patients who, upon treatment, showed a complete clinical response. These 2 groups of cell line